Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cereal Docks Group is a leading Italian industrial group focused on the primary processing of oilseeds and cereals for food, feed, and pharmaceutical applications. The company has established a significant presence in the life sciences sector through its subsidiary, Aethera Biotech, which specializes in plant-based active ingredients. Aethera Biotech utilizes the proprietary CROP (Controlled Replication of Original Plants) platform, an in vitro plant cell culture technology that ensures standardized and sustainable production of phytocomplexes. These high-potency ingredients are primarily targeted at the nutraceutical, dermo-cosmetic, and functional food markets. The group operates multiple production facilities in Italy, emphasizing a circular economy and full supply chain traceability from farm to finished ingredient. By bypassing traditional agricultural constraints, their biotech platform provides consistent quality and high concentrations of active metabolites for health-related applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cereal Docks Group.